Pharmaxis Sells Bronchitol and Aridol Australian Distribution Rights for A$2m

1st Jul 21

Release Date: 01/07/2021 8:24am

  • Pharmaxis sells Australian distribution rights for Bronchitol®and Aridol® in Australia, New Zealand and several Asian territories to BTC Health effective July 1st, 2021
  • $2m distributor appointment fee to be paid to Pharmaxis
  • Streamlining  mannitol respiratory business in line with strategy

Read full media release - pdf

Categories: News and Media